Side effects of long-term treatment with human leukocyte interferon
- PMID: 292735
- DOI: 10.1093/infdis/140.4.560
Side effects of long-term treatment with human leukocyte interferon
Abstract
Twenty-nine patients, 27 of them with osteosarcoma and two with juvenile laryngeal papilloma, were followed for an aggregate period of 365 months, during which time they received long-term treatment with human leukocyte interferon. The interferon was given by intramuscular injection either daily or three times a week; the dose was 3 x 10(6) standard units. During the course of the treatment, 12 distinct symptoms were recognized as possible side effects of the drug; the three most frequent symptoms occurring after injection were fever, local pain, and shivering. All but three of the patients reported between one and five symptoms. Partial purification of the interferon reduced or eliminated some, but not all, of the symptoms. All of the patients were treated on an ambulatory basis, and none had to discontinue the interferon therapy because of the side effects.
Similar articles
-
Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma.Acta Paediatr Scand. 1988 Jul;77(4):619-22. doi: 10.1111/j.1651-2227.1988.tb10718.x. Acta Paediatr Scand. 1988. PMID: 2455956
-
Interferon therapy in juvenile laryngeal papillomatosis.Otolaryngol Head Neck Surg. 1984 Aug;92(4):386-91. doi: 10.1177/019459988409200403. Otolaryngol Head Neck Surg. 1984. PMID: 6207477
-
[Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].Presse Med. 1985 Jun 15;14(24):1317-8. Presse Med. 1985. PMID: 3161020 French.
-
Interferons in the treatment of human cancer.J Clin Oncol. 1984 Apr;2(4):336-52. doi: 10.1200/JCO.1984.2.4.336. J Clin Oncol. 1984. PMID: 6323641 Review.
-
[Critical review of the therapy of juvenile laryngeal papillomas].Laryngol Rhinol Otol (Stuttg). 1984 Aug;63(8):396-400. Laryngol Rhinol Otol (Stuttg). 1984. PMID: 6384705 Review. German.
Cited by
-
Drug-induced hair loss and hair growth. Incidence, management and avoidance.Drug Saf. 1994 Apr;10(4):310-7. doi: 10.2165/00002018-199410040-00005. Drug Saf. 1994. PMID: 8018303 Review.
-
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.Antimicrob Agents Chemother. 1982 Jan;21(1):93-100. doi: 10.1128/AAC.21.1.93. Antimicrob Agents Chemother. 1982. PMID: 6177285 Free PMC article.
-
Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.J Clin Invest. 1985 May;75(5):1496-503. doi: 10.1172/JCI111853. J Clin Invest. 1985. PMID: 3923039 Free PMC article.
-
Toxicity of interferon.Br Med J (Clin Res Ed). 1981 Apr 25;282(6273):1345-8. doi: 10.1136/bmj.282.6273.1345. Br Med J (Clin Res Ed). 1981. PMID: 6165428 Free PMC article. Clinical Trial.
-
Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.Clin Vaccine Immunol. 2014 Dec;21(12):1668-80. doi: 10.1128/CVI.00547-14. Epub 2014 Oct 8. Clin Vaccine Immunol. 2014. PMID: 25298110 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources